Skip to main content Accessibility help
×
Home

Maternal restraint stress during pregnancy in mice induces 11β-HSD1-associated metabolic changes in the livers of the offspring

  • H. Maeyama (a1), T. Hirasawa (a1) (a2), Y. Tahara (a1), C. Obata (a1) (a2), H. Kasai (a3), K. Moriishi (a3), K. Mochizuki (a4) and T. Kubota (a1)...

Abstract

In rats, maternal exposure to restraint stress during pregnancy can induce abnormalities in the cardiovascular and central nervous systems of the offspring. These effects are mediated by long-lasting hyperactivation of the hypothalamic–pituitary–adrenal axis. However, little is known about the potential effects of stress during pregnancy on metabolic systems. We examined the effect of restraint stress in pregnant mice on the liver function of their offspring. The offspring of stressed mothers showed significantly higher lipid accumulation in the liver after weaning than did the controls; this accumulation was associated with increased expression of lipid metabolism-related proteins such as alanine aminotransferase 2 diglyceride acyltransferase 1, peroxisome proliferator-activated receptor gamma and glucocorticoid receptor. Additionally, we observed increased levels of 11β-hydroxysteroid dehydrogenase type 1, an intercellular mediator that converts glucocorticoid from the inactive to the active form, in the foetal and postnatal periods. These results indicate that restraint stress in pregnancy in mice induces metabolic abnormalities via 11β-hydroxysteroid dehydrogenase type 1-related pathways in the foetal liver. It is therefore possible that exposure to stress in pregnant women may be a risk factor for metabolic syndromes (e.g. fatty liver) in children.

Copyright

Corresponding author

*Address for correspondence: T. Hirasawa, Department of Epigenetic Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan. (Email takae@yamanashi.ac.jp)

References

Hide All
1. Godfrey, KM, Barker, DJ. Fetal programming and adult health. Public Health Nutr. 2001; 4, 611624.
2. Gluckman, PD, Hanson, MA. Living with the past: evolution, development, and patterns of disease. Science. 2004; 305, 17331736.
3. Gluckman, PD, Seng, CY, Fukuoka, H, Beedle, AS, Hanson, MA. Low birthweight and subsequent obesity in Japan. Lancet. 2007; 369, 10811082.
4. Painter, RC, de Rooij, SR, Bossuyt, PM, et al. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr. 2006; 84, 322327.
5. St Clair, D, Xu, M, Wang, P, et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959–1961. JAMA. 2005; 294, 557562.
6. Barker, DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261, 412417.
7. Silveira, PP, Portella, AK, Goldani, MZ, Barbieri, MA. Developmental origins of health and disease (DOHaD). Jornal de Pediatria. 2007; 83, 494504.
8. Darnaudéry, M, Maccari, S. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res Rev. 2008; 57, 571585.
9. Igosheva, N, Klimova, O, Anishchenko, T, Glover, V. Prenatal stress alters cardiovascular responses in adult rats. J Physiol. 2004; 557, 273285.
10. Igosheva, N, Taylor, PD, Poston, L, Glover, V. Prenatal stress in the rat results in increased blood pressure responsiveness to stress and enhanced arterial reactivity to neuropeptide Y in adulthood. J Physiol. 2007; 582(Pt 2), 665674.
11. Viltart, O, Mairesse, J, Darnaudéry, M, et al. Prenatal stress alters Fos protein expression in hippocampus and locus coeruleus stress-related brain structures. Psychoneuroendocrinology. 2006; 31, 769780.
12. Morley-Fletcher, S, Darnaudéry, M, Mocaer, E, et al. Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT(1A) receptor mRNA in prenatally stressed rats. Neuropharmacology. 2004; 47, 841847.
13. Li, J, Olsen, J, Vestergaard, M, et al. Prenatal stress exposure related to maternal bereavement and risk of childhood overweight. PLoS One. 2010; 5, e11896.
14. Paterson, JM, Morton, NM, Fievet, C, et al. Metabolic syndrome without obesity: hepatic overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. PNAS. 2004; 101, 70887093.
15. Gandhi, K, Adhikari, P, Basu, A, Achappa, B. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population. Metab Syndr Relat Disord. 2013; 11, 397402.
16. Moon, SS, Lee, YS, Kim, JG, Lee, IK. Association of 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity. Diabetes Res Clin Pr. 2013; 99, 343350.
17. Fujisawa, Y, Nakagawa, Y, Li, RS, Liu, YJ, Ohzeki, T. Diabetic pregnancy in rats leads to impaired glucose metabolism in offspring involving tissue-specific dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 expression. Life Sci. 2007; 81, 724731.
18. McTernan, CL, Draper, N, Nicholson, H, et al. Reduced placental 11 beta hydroxysteroid dehydrogenase type2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab. 2001; 86, 49794983.
19. Takaya, J, Iharada, A, Okihana, H, Kaneko, K. Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatic hydroxysteroid dehydrogenase-2 promoter of the offspring. Epigenetics. 2011; 6, 573578.
20. Morton, NM, Holmes, MC, Fiévet, C, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem. 2001; 276, 4129341300.
21. Morton, NM, Paterson, JM, Masuzaki, H, et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes. 2004; 53, 931938.
22. Anderson, A, Walker, BR. 11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease. Drugs. 2013; 73, 13851393.
23. Harno, E, Cottrell, EC, Yu, A, et al. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms. Endocrinology. 2013; 154, 45804593.
24. Matsusue, K, Haluzik, M, Lambert, G, et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003; 111, 737747.
25. Masuzaki, H, Paterson, J, Shinyama, H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001; 294, 21662170.
26. Liu, Y, Park, F, Pietrusz, JL, et al. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol Genom. 2008; 32, 343351.
27. Berthiaume, M, Laplante, M, Festuccia, W, et al. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology. 2007; 148, 23912397.
28. Arai, K, Soga, T, Ohata, H, et al. Effects of food restriction on peroxisome proliferator-activated receptor-gamma and glucocorticoid receptor signaling in adipose tissues of normal rats. Metabolism. 2004; 53, 2836.
29. Rhee, SD, Kim, CH, Park, JS, et al. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. Eur J Pharmacol. 2012; 691, 918.
30. Lillycrop, KA, Phillips, ES, Jackson, AA, Hanson, MA, Burdge, GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005; 135, 13821386.
31. Lillycrop, KA, Phillips, ES, Torrens, C, et al. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr. 2008; 100, 278282.
32. Chapman, K, Holmes, M, Seckl, J. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013; 93, 11391206.
33. Torrecilla, E, Fernández-Vázquez, G, Vicent, D, et al. Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients. Obesity Surg. 2012; 22, 478486.
34. Ahmed, A, Rabbitt, E, Brady, T, et al. A switch in hepatic cortisol metabolism across the spectrum of non-alcoholic fatty liver disease. PLoS One. 2012; 7, e29531.
35. Rueda-Clausen, CF, Dolinsky, VW, Morton, JS, et al. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes. 2011; 60, 507516.
36. Nobili, V, Alisi, A, Panera, N, Agostoni, C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Ped Endocrinol Rev. 2008; 6, 241247.
37. Alisi, A, Panera, N, Agostoni, C, Nobili, V. Intrauterine growth retardation and nonalcoholic fatty liver disease in children. Int J Endocrinol. 2011; 269853.
38. Nobili, V, Alisi, A, Grimaldi, C, et al. Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity? Pediatr Obes. 2014; 9, e99e102.
39. Andrews, RC, Rooyackers, O, Walker, BR. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 2003; 88, 285291.
40. Vicker, N, Su, X, Ganeshapillai, D, et al. Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol. 2007; 104, 123129.
41. Kim, JG, Jung, HS, Kim, KJ, Min, SS, Yoon, BJ. Basal blood corticosterone level is correlated with susceptibility to chronic restraint stress in mice. Neurosci Lett. 2013; 555, 137142.
42. Mairesse, J, Lesage, J, Breton, C, et al. Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab. 2007; 292, E1526E1533.
43. Hollis, G, Huber, R. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus. Diabetes Obes Metab. 2011; 13, 16.
44. Andrews, RC, Walker, BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999; 96, 513523.

Keywords

Type Description Title
PDF
Supplementary materials

Maeyama supplementary material
Figure S1

 PDF (577 KB)
577 KB

Maternal restraint stress during pregnancy in mice induces 11β-HSD1-associated metabolic changes in the livers of the offspring

  • H. Maeyama (a1), T. Hirasawa (a1) (a2), Y. Tahara (a1), C. Obata (a1) (a2), H. Kasai (a3), K. Moriishi (a3), K. Mochizuki (a4) and T. Kubota (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed